BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 1.03.1994

International Conference on Harmonisation; Draft Guideline on Dose Selection for Carcinogenicity Studies of Pharmaceuticals; Availability

The FDA is publishing a draft guideline on dose selection for carcinogenicity studies of pharmaceuticals, prepared by the ICH Expert Working Group on Safety, to ensure sound scientific principles in dose selection for drug registration.

Source: Federal Register — Health and Human ServicesOpen original release →